Association between caffeine consumption and nonalcoholic fatty liver disease: A systemic review and meta-analysis

Therapeutic Advances in Gastroenterology

Volumn 9, Issue 1, 2016, Pages 113-120

  Shen, Huafeng ^a   Rodriguez, Andrea C ^b   Shiani, Ashok ^b   Lipka, Seth ^b   Shahzad, Ghulamullah ^a   Mustacchia, Paul ^a   Kumar, Ambuj ^b  

^a NASSAU UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

caffeine; coffee; non alcoholic fatty liver disease

Indexed keywords

ASPARTATE AMINOTRANSFERASE; CAFFEINE; GAMMA GLUTAMYLTRANSFERASE;

AGE; ALCOHOL CONSUMPTION; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; COFFEE; DIABETES MELLITUS; DISEASE ASSOCIATION; ETHNICITY; FOOD INTAKE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GENDER; HUMAN; LIVER FIBROSIS; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; PREVALENCE; PRIORITY JOURNAL; REVIEW; SMOKING; SYSTEMATIC REVIEW; WAIST CIRCUMFERENCE;

EID: 84951737163     PISSN: 1756283X     EISSN: 17562848     Source Type: Journal    
DOI: 10.1177/1756283X15593700     Document Type: Review

References (27)

1. Anty R. Marjoux S. Iannelli A. Patouraux S. Schneck A. Bonnafous S. et al. (2012) Regular coffee but not espresso drinking is protective against fibrosis in a cohort mainly composed of morbidly obese European women with NAFLD undergoing bariatric surgery. J Hepatol 57: 1090–1096.
2. Anty R. Marjoux S. Iannelli A. Pariente A. Tran A. (2013) Reply to: “regular coffee: a magic bullet or a naked gun? Regular coffee but not espresso drinking is protective against fibrosis in NAFLD”. J Hepatol 58: 1265–1266.
3. Bambha K. Wilson L. Unalp A. Loomba R. Neuschwander-Tetri B. Brunt E. et al. (2014) Coffee consumption in NAFLD patients with lower insulin resistance is associated with lower risk of severe fibrosis. Liver Int 34: 1250–1258.
4. Birerdinc A. Stepanova M. Pawloski L. Younossi Z. (2012) Caffeine is protective in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther 35: 76–82.
5. Bravi F. Bosetti C. Tavani A. Bagnardi V. Gallus S. Negri E. et al. (2007) Coffee drinking and hepatocellular carcinoma risk: a meta-analysis. Hepatology 46: 430–435.
6. Cadden I. Partovi N. Yoshida E. (2007) Review article: possible beneficial effects of coffee on liver disease and function. Aliment Pharmacol Ther 26 (1):1–8.
7. Catalano D. Martines G. Tonzuso A. Pirri C. Trovato F. Trovato G. (2010) Protective role of coffee in non-alcoholic fatty liver disease (NAFLD). Dig Dis Sci 55: 3200–3206.
8. Chen S. Teoh N. Chitturi S. Farrell G. (2014) Coffee and non-alcoholic fatty liver disease: brewing evidence for hepatoprotection? J Gastroenterol Hepatol 29: 435–441.
9. Frary C. Johnson R. Wang M. (2005) Food sources and intakes of caffeine in the diets of persons in the United States. J Am Diet Assoc 105: 110–113.
10. Freedman N. Park Y. Abnet C. Hollenbeck A. Sinha R. (2012) Association of coffee drinking with total and cause-specific mortality. N Engl J Med 366: 1891–1904.
11. Gressner O. (2009) Less Smad 2 is good for you! A scientific update on coffee's liver benefits. Hepatology 50: 970–978.
12. Gutierrez-Grobe Y. Chavez-Tapia N. Sanchez-Valle V. Gavilanes-Espinar J. Ponciano-Rodriguez G. Uribe M. et al. (2012) High coffee intake is associated with lower grade nonalcoholic fatty liver disease: the role of peripheral antioxidant activity. Ann Hepatol 11: 350–355.
13. Heckman M. Weil J. Gonzalez de Mejia E. (2010) Caffeine (1, 3, 7-trimethylxanthine) in foods: a comprehensive review on consumption, functionality, safety, and regulatory matters. J Food Sci 75 (3): R77–R87.
14. Higgins J. Thompson S. Deeks J. Altman D. (2003) Measuring inconsistency in meta-analyses. BMJ 327: 557–560.
15. Kalthoff S. Ehmer U. Freiberg N. Manns M. Strassburg C. (2010) Coffee induces expression of glucuronosyltransferases by the aryl hydrocarbon receptor and Nrf 2 in liver and stomach. Gastroenterology 139:1699–1710, 1710.e1–2.
16. Liu R. Guo X. Park Y. Huang X. Sinha R. Freedman N. et al. (2012) Caffeine intake, smoking, and risk of Parkinson disease in men and women. Am J Epidemiol 175: 1200–1207.
17. Mann C. (2003) Observational research methods. Research design II: cohort, cross sectional, and case-control studies. Emerg Med J 20 (1):54–60.
18. Marchesini G. Brizi M. Bianchi G. Tomassetti S. Bugianesi E. Lenzi M. et al. (2001) Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 50 (8):1844–1850.
19. Mitchell D. Knight C. Hockenberry J. Teplansky R. Hartman T. (2014) Beverage caffeine intakes in the US Food Chem Toxicol 63: 136–142.
20. Modi A. Feld J. Park Y. Kleiner D. Everhart J. Liang T. et al. (2010) Increased caffeine consumption is associated with reduced hepatic fibrosis. Hepatology 51: 201–209.
21. Molloy J. Calcagno C. Williams C. Jones F. Torres D. Harrison S. (2012) Association of coffee and caffeine consumption with fatty liver disease, nonalcoholic steatohepatitis, and degree of hepatic fibrosis. Hepatology 55: 429–436.
22. Paynter N. Yeh H. Voutilainen S. Schmidt M. Heiss G. Folsom A. et al. (2006) Coffee and sweetened beverage consumption and the risk of type 2 diabetes mellitus: the atherosclerosis risk in communities study. Am J Epidemiol 164: 1075–1084.
23. Ruhl C. Everhart J. (2005) Coffee and tea consumption are associated with a lower incidence of chronic liver disease in the United States. Gastroenterology 129: 1928–1936.
24. Shen H. Lipka S. Kumar A. Mustacchia P. (2014) Association between nonalcoholic fatty liver disease and colorectal adenoma: a systemic review and meta-analysis. J Gastrointest Oncol 5: 440–446.
25. Shim S. Jun D. Kim E. Saeed W. Lee K. Lee H. et al. (2013) Caffeine attenuates liver fibrosis via defective adhesion of hepatic stellate cells in cirrhotic model. J Gastroenterol Hepatol 28: 1877–1884.
26. Stroup D. Berlin J. Morton S. Olkin I. Williamson G. Rennie D. et al. (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283: 2008–2012.
27. Wilson K. Kasperzyk J. Rider J. Kenfield S. van Dam R. Stampfer M. et al. (2011) Coffee consumption and prostate cancer risk and progression in the Health Professionals Follow-up Study. J Natl Cancer Inst 103: 876–884.